Nanovibronix (NASDAQ:FEED) Stock Scheduled to Reverse Split on Tuesday, September 1st
by Michael Walen · The Markets DailyShares of Nanovibronix, Inc. (NASDAQ:FEED – Free Report) are scheduled to reverse split on the morning of Tuesday, September 1st. The 1-12 reverse split was recently announced. The number of shares owned by shareholders will be adjusted after the market closes on Monday, August 31st.
Nanovibronix Price Performance
FEED traded down $0.02 during midday trading on Friday, hitting $0.34. 465,195 shares of the company traded hands, compared to its average volume of 1,623,298. The company’s 50-day moving average is $0.44 and its 200 day moving average is $1.20. Nanovibronix has a 52 week low of $0.29 and a 52 week high of $17.40.
Nanovibronix (NASDAQ:FEED – Get Free Report) last posted its earnings results on Monday, August 17th. The company reported ($1.98) earnings per share (EPS) for the quarter. Nanovibronix had a negative net margin of 1,093.61% and a negative return on equity of 60.73%. The company had revenue of $0.24 million for the quarter.
Wall Street Analysts Forecast Growth
Several equities research analysts recently issued reports on the stock. Wall Street Zen upgraded shares of Nanovibronix from a “strong sell” rating to a “sell” rating in a report on Sunday, July 12th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Nanovibronix in a research note on Tuesday, July 21st. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock currently has an average rating of “Sell”.
Get Our Latest Report on Nanovibronix
Insider Transactions at Nanovibronix
In other Nanovibronix news, insider Christian Michael Glibert sold 210,000 shares of the business’s stock in a transaction dated Monday, June 22nd. The stock was sold at an average price of $0.69, for a total transaction of $144,900.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Insiders own 12.20% of the company’s stock.
Nanovibronix Company Profile
Nanovibronix (NASDAQ: FEED) is a medical device company focused on the development and commercialization of non‑invasive therapeutic ultrasound technologies for clinical and consumer healthcare applications. The company’s product portfolio centers on wearable ultrasound devices designed to deliver low‑intensity acoustic energy to soft tissue with the objective of promoting wound healing and reducing pain. Nanovibronix positions its technology as an alternative or adjunct to conventional wound‑care and analgesic therapies, aiming to address chronic and acute conditions that are managed in both outpatient and home settings.
The company concentrates its commercial efforts on supplying hospitals, wound‑care clinics, long‑term care facilities and patients requiring home‑based therapies.